ライフサイエンスコーパス: hyperactivity disorder

1 sorder, schizophrenia, and attention-deficit/hyperactivity disorder).

2 (autism spectrum disorders/attention deficit hyperactivity disorder).

3 on, anxiety disorders, and attention-deficit/hyperactivity disorder.

4 g depression, anxiety, and attention-deficit/hyperactivity disorder.

5 ion and cognition, such as attention-deficit/hyperactivity disorder.

6 white matter in boys with attention-deficit/hyperactivity disorder.

7 the exclusion of comorbid attention-deficit/hyperactivity disorder.

8 nia, bipolar disorder, and attention-deficit/hyperactivity disorder.

9 s, particularly autism and attention-deficit hyperactivity disorder.

10 order, autism, anxiety and attention deficit/hyperactivity disorder.

11 tism spectrum disorder, or attention-deficit/hyperactivity disorder.

12 syndrome, autism, and attention deficit and hyperactivity disorder.

13 pathological gambling, and attention deficit hyperactivity disorder.

14 ve-compulsive disorder and attention-deficit hyperactivity disorder.

15 25 (4.8%) met criteria for attention-deficit/hyperactivity disorder.

16 or depressive disorder, or attention-deficit/hyperactivity disorder.

17 riability in patients with attention deficit hyperactivity disorder.

18 chiatric disorders such as attention-deficit hyperactivity disorder.

19 isorder, schizophrenia and attention deficit-hyperactivity disorder.

20 ce Test and diagnosis with attention-deficit/hyperactivity disorder.

21 chiatric disorders such as attention deficit hyperactivity disorder.

22 erity, tic medication, and attention deficit hyperactivity disorder.

23 schizophrenia, autism, and attention deficit hyperactivity disorder.

24 in patients with comorbid attention-deficit/hyperactivity disorder.

25 k of anxiety disorders and attention-deficit/hyperactivity disorder.

26 ons, eating disorders, and attention deficit/hyperactivity disorder.

27 typically associated with attention deficit hyperactivity disorder.

28 RR, 4.3; 95% CI, 2.3-8.2), attention-deficit/hyperactivity disorder (189 cases [5.3%] vs 180 controls

29 of 28% (95% CI 25-32) for attention-deficit hyperactivity disorder; 20% (17-23) for anxiety disorder

30 r (94.2 [1.69]; P = .004), attention-deficit/hyperactivity disorder (96.3 [0.91]; P = .002), oppositi

31 Attention-deficit/hyperactivity disorder according to DSM-IV diagnostic cr

32 pectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) - prevalent and often high

33 Attention-deficit/hyperactivity disorder (ADHD) affects 39 million people

34 trum disorder (ASD) and/or attention deficit hyperactivity disorder (ADHD) and 5,000 controls were an

35 Attention-deficit/hyperactivity disorder (ADHD) and anxiety-related disord

36 diator between symptoms of attention deficit hyperactivity disorder (ADHD) and associated cognitive a

37 PBDEs and intelligence or Attention Deficit/Hyperactivity Disorder (ADHD) and attention-related beha

38 P), major depression (MD), attention-deficit hyperactivity disorder (ADHD) and autism (AUT).

39 Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disord

40 phen exposure and risks of attention deficit hyperactivity disorder (ADHD) and autism spectrum disord

41 opmental disorders such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disord

42 netic loci associated with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disord

43 d between extraversion and attention-deficit-hyperactivity disorder (ADHD) and between openness and s

44 is between childhood onset attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD)

45 Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BPD)

46 Attention-Deficit/Hyperactivity Disorder (ADHD) and conduct disorder (CD)

47 that children treated for attention deficit hyperactivity disorder (ADHD) and depression have more s

48 nic risk scores (PRSs) for attention deficit hyperactivity disorder (ADHD) and depression, derived us

49 Although attention-deficit/hyperactivity disorder (ADHD) and eating disorders (EDs)

50 been effective in treating attention-deficit/hyperactivity disorder (ADHD) and is currently the first

51 xcessive mind wandering in attention-deficit/hyperactivity disorder (ADHD) and its association with i

52 al role in the etiology of attention deficit hyperactivity disorder (ADHD) and its comorbidity with o

53 Patients with attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive d

54 s used clinically to treat attention-deficit/hyperactivity disorder (ADHD) and off-label as a perform

55 frequently co-occurs with attention-deficit/hyperactivity disorder (ADHD) and often leads to antisoc

56 m spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD) and schizophrenia (SCZ).

57 tric conditions, including attention deficit hyperactivity disorder (ADHD) and substance use disorder

58 n the relationship between attention-deficit hyperactivity disorder (ADHD) and younger relative age i

59 atric disorders, including attention deficit hyperactivity disorder (ADHD) and, more recently, Autism

60 tism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD) are associated with comple

61 Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk o

62 Individuals with attention-deficit/hyperactivity disorder (ADHD) are at greater risk for ac

63 Individuals with attention deficit hyperactivity disorder (ADHD) are at increased risk for

64 pulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD) are clinically and biologi

65 ated that individuals with attention-deficit/hyperactivity disorder (ADHD) are more likely to experie

66 rsistence and remission of attention-deficit/hyperactivity disorder (ADHD) are poorly understood.

67 Epilepsy and attention-deficit/hyperactivity disorder (ADHD) are strongly associated; h

68 anxiety, irritability, and attention-deficit/hyperactivity disorder (ADHD) as common, impactful, co-o

69 adult outcome of childhood attention deficit hyperactivity disorder (ADHD) could guide novel interven

70 n the etiology of clinical attention-deficit/hyperactivity disorder (ADHD) diagnoses and symptoms in

71 Attention-deficit/hyperactivity disorder (ADHD) diagnosis is based on repo

72 ectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD) frequently co-occur.

73 Attention-deficit/hyperactivity disorder (ADHD) frequently co-occurs with

74 uestioned the stability of attention-deficit hyperactivity disorder (ADHD) from childhood to adulthoo

75 Attention-deficit/hyperactivity disorder (ADHD) has an uncertain etiology,

76 amine for the treatment of attention deficit-hyperactivity disorder (ADHD) has been increasing.

77 Attention-deficit/hyperactivity disorder (ADHD) has been often found to be

78 Although the prevalence of attention-deficit/hyperactivity disorder (ADHD) has been stable over the p

79 spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD) have 2-3 times increased h

80 Neuroimaging studies of attention-deficit/hyperactivity disorder (ADHD) have most commonly reporte

81 ng (fMRI) studies of adult attention-deficit/hyperactivity disorder (ADHD) have revealed various ADHD

82 Previous studies of attention-deficit hyperactivity disorder (ADHD) have suggested that struct

83 ences were associated with attention-deficit/hyperactivity disorder (ADHD) in a recent multi-site, me

84 erion for the diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults, but recently th

85 egnancy has been linked to attention-deficit/hyperactivity disorder (ADHD) in children, but concerns

86 p) vaccination and risk of attention-deficit/hyperactivity disorder (ADHD) in offspring.

87 medications used to treat attention-deficit/hyperactivity disorder (ADHD) increase sympathetic tone

88 Attention deficit hyperactivity disorder (ADHD) is a childhood-onset neuro

89 Attention deficit/hyperactivity disorder (ADHD) is a common and heritable

90 Attention deficit hyperactivity disorder (ADHD) is a common and highly her

91 Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing

92 Attention-deficit hyperactivity disorder (ADHD) is a common childhood beha

93 Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopme

94 Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopme

95 Attention deficit hyperactivity disorder (ADHD) is a common neuropsychiatr

96 Attention deficit hyperactivity disorder (ADHD) is a common, highly herita

97 Importance: Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelo

98 Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevelo

99 Attention-deficit/hyperactivity disorder (ADHD) is a heritable, chronic, n

100 Attention deficit/hyperactivity disorder (ADHD) is a highly heritable chil

101 Attention deficit hyperactivity disorder (ADHD) is a highly heritable psyc

102 Attention-deficit/hyperactivity disorder (ADHD) is a major sequela of trau

103 Attention deficit hyperactivity disorder (ADHD) is a multifactorial disord

104 Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental di

105 Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental di

106 Attention-deficit hyperactivity disorder (ADHD) is a prevalent and highly

107 Attention-deficit/hyperactivity disorder (ADHD) is a prevalent development

108 Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for suici

109 Attention-deficit/hyperactivity disorder (ADHD) is a severely impairing ne

110 Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevel

111 Attention-deficit/hyperactivity disorder (ADHD) is associated with high ra

112 Attention-deficit hyperactivity disorder (ADHD) is associated with pervasi

113 Attention-deficit/hyperactivity disorder (ADHD) is associated with structu

114 Recognition that adult attention-deficit/hyperactivity disorder (ADHD) is common, seriously impai

115 Attention-deficit/hyperactivity disorder (ADHD) is conceptualized as a neu

116 Attention-deficit/hyperactivity disorder (ADHD) is emblematic of the probl

117 ated change in symptoms of attention-deficit/hyperactivity disorder (ADHD) is heritable.

118 Although attention-deficit hyperactivity disorder (ADHD) is highly heritable, and l

119 Although attention-deficit/hyperactivity disorder (ADHD) is highly prevalent in ado

120 es (PFAS) exposure and attention deficit and hyperactivity disorder (ADHD) is inconclusive.

121 pectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) is increasingly appreciate

122 Attention-deficit/hyperactivity disorder (ADHD) is now recognized to occur

123 Attention deficit and hyperactivity disorder (ADHD) is often assumed to be ass

124 Attention-deficit/hyperactivity disorder (ADHD) is the most common childho

125 ldren and adolescents with attention deficit hyperactivity disorder (ADHD) is unclear.

126 and inattention related to attention deficit hyperactivity disorder (ADHD) may increase food intake a

127 Attention-deficit/hyperactivity disorder (ADHD) medication is one of the m

128 Attention-deficit/hyperactivity disorder (ADHD) often persists into adoles

129 g adults without childhood attention deficit hyperactivity disorder (ADHD) often present to clinics s

130 ment might protect against attention-deficit hyperactivity disorder (ADHD) or moderate the symptoms o

131 Symptoms of attention-deficit/hyperactivity disorder (ADHD) run a variable course thro

132 Childhood attention deficit hyperactivity disorder (ADHD) shows a highly variable co

133 Attention-deficit/hyperactivity disorder (ADHD) shows substantial heritabi

134 een putative biomarkers of attention-deficit/hyperactivity disorder (ADHD) symptomatology and genetic

135 Attention-deficit/hyperactivity disorder (ADHD) symptoms are most commonly

136 strength at rest predicted attention-deficit/hyperactivity disorder (ADHD) symptoms in an independent

137 d the effects of childhood attention deficit hyperactivity disorder (ADHD) symptoms, both inattention

138 ategorical ASD diagnosis); attention-deficit/hyperactivity disorder (ADHD) traits (4 versions of Conn

139 scores (PRSs) for ASD and attention-deficit/hyperactivity disorder (ADHD) using genome-wide associat

140 rder, major depression and attention deficit hyperactivity disorder (ADHD) using genomic data from 15

141 For many years, attention-deficit hyperactivity disorder (ADHD) was thought to be a childh

142 tive mechanisms underlying attention-deficit hyperactivity disorder (ADHD), a highly heritable disord

143 fat-free mass, whereas (2) attention-deficit/hyperactivity disorder (ADHD), alcohol dependence, insom

144 n children and adults with attention deficit hyperactivity disorder (ADHD), although nonreplications

145 g intellectual disability, attention deficit/hyperactivity disorder (ADHD), and autism spectrum disor

146 , variable expressivity of attention deficit hyperactivity disorder (ADHD), and motor delay.

147 ldren and adolescents with attention deficit hyperactivity disorder (ADHD), as frequently prescribed

148 Attention deficit hyperactivity disorder (ADHD), autism spectrum disorder

149 ciation studies (TWASs) of attention deficit hyperactivity disorder (ADHD), autism spectrum disorder,

150 nconstant features include attention-deficit/hyperactivity disorder (ADHD), autism, mild facial dysmo

151 genetic susceptibility of Attention-Deficit/Hyperactivity Disorder (ADHD), but without much success.

152 al disabilities, including attention-deficit hyperactivity disorder (ADHD), intellectual disability (

153 Attention-deficit hyperactivity disorder (ADHD), like other psychiatric di

154 oride for the treatment of attention-deficit/hyperactivity disorder (ADHD), little is known about age

155 rmacological treatment for attention-deficit hyperactivity disorder (ADHD), might increase the risk o

156 Attention-deficit hyperactivity disorder (ADHD), one of the most common ps

157 ms of depression, anxiety, attention/deficit hyperactivity disorder (ADHD), oppositional defiant diso

158 ter among individuals with attention-deficit/hyperactivity disorder (ADHD), potentially due to defici

159 ted behavioral hallmark of attention-deficit/hyperactivity disorder (ADHD), strongly influences addic

160 pectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD), the entire range of neuro

161 ating depression, anxiety, attention-deficit hyperactivity disorder (ADHD), Tourette syndrome, post-t

162 stand the underpinnings of attention-deficit/hyperactivity disorder (ADHD), we targeted the relations

163 ition is a core deficit of attention deficit hyperactivity disorder (ADHD), which is a common childho

164 sed with schizophrenia and attention deficit hyperactivity disorder (ADHD), which share attentional i

165 ity among individuals with attention deficit hyperactivity disorder (ADHD), yet associations between

166 a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putat

167 ducational attainment, and attention deficit hyperactivity disorder (ADHD).

168 ed with the development of attention-deficit/hyperactivity disorder (ADHD).

169 pectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD).

170 iatric disorders including attention-deficit/hyperactivity disorder (ADHD).

171 ghly effective in treating attention-deficit/hyperactivity disorder (ADHD).

172 ulsive disorder (OCD), and attention deficit hyperactivity disorder (ADHD).

173 on of which is a factor in attention-deficit/hyperactivity disorder (ADHD).

174 atopic dermatitis (AD) and attention-deficit/hyperactivity disorder (ADHD).

175 ttention problems, such as attention deficit/hyperactivity disorder (ADHD).

176 s have been identified for attention-deficit/hyperactivity disorder (ADHD).

177 n children and adults with attention deficit hyperactivity disorder (ADHD).

178 S), and characteristics of attention-deficit/hyperactivity disorder (ADHD).

179 ldren and adolescents with attention-deficit/hyperactivity disorder (ADHD).

180 and could be relevant for attention-deficit/hyperactivity disorder (ADHD).

181 mal model for the study of attention deficit hyperactivity disorder (ADHD).

182 ychopathologies, including attention deficit hyperactivity disorder (ADHD).

183 iatric disorders including attention deficit hyperactivity disorder (ADHD).

184 predispose individuals to attention-deficit/hyperactivity disorder (ADHD).

185 pectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD).

186 ellum has been reported in attention-deficit/hyperactivity disorder (ADHD).

187 r region of this gene with attention-deficit/hyperactivity disorder (ADHD).

188 used for the treatment of attention-deficit/hyperactivity disorder (ADHD).

189 ity (HRV) in children with Attention-Deficit/Hyperactivity Disorder (ADHD).

190 all cognition in boys with attention deficit hyperactivity disorder (ADHD).

191 c variants confer risk for attention deficit hyperactivity disorder (ADHD).

192 al changes associated with attention-deficit/hyperactivity disorder (ADHD).

193 articularly drug abuse and attention-deficit/hyperactivity disorder (ADHD).

194 variant has been linked to attention-deficit/hyperactivity disorder (ADHD); however, the underlying m

195 epeats have been linked to attention-deficit/hyperactivity disorder (ADHD); however, the underlying m

196 ldren and adolescents with attention-deficit/hyperactivity disorder (ADHD)?

197 autism spectrum disorder, attention deficit hyperactivity disorder (ADHD)] in children of preeclampt

198 a Exchange (ABIDE) and the Attention-Deficit Hyperactivity Disorder (ADHD-200) databases.

199 ), schizophrenia (SZ), and Attention-Deficit-Hyperactivity-Disorder (ADHD), but their impact on funct

200 opmental disorders (NDDs) (attention deficit hyperactivity disorder [ADHD], autism spectrum disorder

201 depressive disorder [MDD], attention deficit/hyperactivity disorder [ADHD], bipolar disorder, schizop

202 were clinically at risk of attention deficit hyperactivity disorders after Bonferroni correction for

203 tween the Pro33 allele and attention-deficit hyperactivity disorder and ASDs.

204 cribe an increased rate of attention-deficit hyperactivity disorder and autism spectrum disorder, alo

205 ng infantile parkinsonism, attention-deficit/hyperactivity disorder and autism spectrum disorder.

206 ders were observed in both attention-deficit/hyperactivity disorder and autism spectrum disorder.

207 opmental disorders such as attention deficit hyperactivity disorder and autism spectrum disorder.

208 ), behavioral disturbance (attention deficit hyperactivity disorder and conduct disorder), psychosis-

209 autism spectrum disorder, attention-deficit hyperactivity disorder and Down syndrome have potential

210 atric disorders, including attention-deficit hyperactivity disorder and drug addiction.

211 frequent association with attention deficit hyperactivity disorder and impulse control disorders.

212 Some conditions, such as attention-deficit/hyperactivity disorder and inpatient well-newborn care,

213 ng from childhood, such as attention deficit hyperactivity disorder and intellectual disability, to l

214 nattention associated with attention-deficit/hyperactivity disorder and may likewise play a role in d

215 lation in association with Attention Deficit Hyperactivity Disorder and Mental Development Index at a

216 schizophrenia, depression, attention-deficit hyperactivity disorder and substance abuse disorders.

217 ssive-compulsive disorder, attention deficit hyperactivity disorder and Tourette's syndrome.

218 Attention-deficit/hyperactivity disorder and well-dental care (including d

219 mood dysregulation, and/or attention-deficit/hyperactivity disorders and 22 healthy youths.

220 ility, facial dysmorphism, attention-deficit hyperactivity disorder) and revealed further disease mec

221 ease, schizophrenia, and attention deficient-hyperactivity disorder, and abnormalities in social memo

222 ase, schizophrenia, attention deficiency and hyperactivity disorder, and addiction.

223 disorder, cross disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa) and 17 non

224 patient well-newborn care, attention-deficit/hyperactivity disorder, and asthma among all conditions.

225 ssive-compulsive disorder, attention-deficit/hyperactivity disorder, and autism spectrum disorder in

226 , including schizophrenia, attention deficit/hyperactivity disorder, and autism spectrum disorders.

227 h as Huntington's disease, attention deficit hyperactivity disorder, and dementia, have not found any

228 sorder, drug use disorder, attention deficit hyperactivity disorder, and personality disorders had a

229 sorders, including autism, attention-deficit/hyperactivity disorder, and schizophrenia.

230 notypes, including autism, attention-deficit hyperactivity disorder, and speech and motor deficits.

231 athology, such as anxiety, attention deficit hyperactivity disorder, and substance use.

232 enia, bipolar disorder and attention-deficit/hyperactivity disorder are located in protein-coding exo

233 en considering symptoms of attention-deficit/hyperactivity disorder, as it may have implications for

234 adults, including autism, attention deficit hyperactivity disorder, asthma, and allergies.

235 yslexia risk with PGSs for attention deficit hyperactivity disorder (at p(T) = 0.05 in the training G

236 iatric disorders including attention deficit hyperactivity disorder, autism and bipolar disorder(2,5)

237 disability, schizophrenia, attention-deficit hyperactivity disorder, autism spectrum disorder, anxiet

238 isorder, bipolar disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, intell

239 ric diagnosis of interest (attention-deficit/hyperactivity disorder, autism spectrum disorder, schizo

240 rs in offspring, including attention deficit/hyperactivity disorder, autism, and schizophrenia.

241 between schizophrenia and attention deficit hyperactivity disorder/autism.

242 r clinical development for attention deficit hyperactivity disorder, binge eating disorder, cocaine a

243 moking with drug and AUDs, attention-deficit hyperactivity disorder, bipolar disorder and antisocial

244 diabetes, waist-hip ratio, attention deficit hyperactivity disorder, bipolar disorder, major depressi

245 tism spectrum disorder and attention-deficit/hyperactivity disorder, but is much less so for bipolar

246 xposed were diagnosed with attention-deficit/hyperactivity disorder by age 15 years.

247 gotic twins discordant for attention deficit hyperactivity disorder can elucidate mechanisms that con

248 but represented 55.9% when attention-deficit/hyperactivity disorder codes were excluded.

249 ty in patients with autism/attention deficit hyperactivity disorder, compared with respective control

250 vous system stimulants for attention deficit/hyperactivity disorder, disease-modifying therapies for

251 of why many children with attention deficit hyperactivity disorder do not outgrow the disorder by ad

252 tensive drugs, sleep aids, attention-deficit/hyperactivity disorder drugs, and antidepressant drugs)

253 of insomnia [sleep aids], attention-deficit/hyperactivity disorder drugs, antidepressant drugs, and

254 schizophrenia, depression, attention-deficit/hyperactivity disorder, eating disorders, autism spectru

255 used extensively to treat attention deficit hyperactivity disorder, even though its effects on cogni

256 or depressive disorder and attention-deficit hyperactivity disorder from their controls but moderatel

257 of attention--symptoms of attention deficit hyperactivity disorder--from resting-state connectivity

258 The adult form of attention-deficit/hyperactivity disorder has a prevalence of up to 5% and

259 2.02 [95% CI, 1.80-2.26]; attention-deficit/hyperactivity disorder HR, 2.21 [95% CI, 2.04-2.39]).

260 3 [95% CI, 0.62-1.13]), or attention-deficit/hyperactivity disorder (HR, 0.99 [95% CI, 0.79-1.25]).

261 l age in later symptoms of attention-deficit/hyperactivity disorder in 105 individuals (49 males and

262 , aggressive behavior, and attention-deficit/hyperactivity disorder in children were assessed using m

263 schizophrenia, autism, and attention-deficit/hyperactivity disorder in humans.

264 disorders, depression and attention deficit hyperactivity disorder in independent clinical samples.

265 tism spectrum disorder and attention-deficit/hyperactivity disorder in offspring.

266 predicts later symptoms of attention-deficit/hyperactivity disorder in the euploid population, this h

267 e of amphetamines to treat attention deficit hyperactivity disorders in children provides a compellin

268 nd effective treatment for attention-deficit/hyperactivity disorder, in healthy adults.

269 Attention-deficit/hyperactivity disorder is frequently reported in individ

270 bipolar disorder (n = 40), attention-deficit/hyperactivity disorder (n = 37), schizophrenia (n = 29),

271 17; n unique genes = 13), attention deficit hyperactivity disorder (n associations = 19; n unique ge

272 =3540), autism (N=16 146), attention-deficit/hyperactivity disorder (N=18 726) and affective disorder

273 2; anxiety disorder, N=42; attention deficit hyperactivity disorder, N=40; and healthy volunteers, N=

274 mitter dysregulation, e.g. attention deficit hyperactivity disorder or Alzheimer's disease.

275 association with comorbid attention-deficit/hyperactivity disorder or IQ, age range was associated w

276 The risk of attention-deficit hyperactivity disorder (OR 6.9, 3.2-15.1), oppositional

277 : 1.4, 7.7) higher odds of attention deficit/hyperactivity disorder problems compared with children w

278 f clinical symptom scales (attention-deficit/hyperactivity disorder, psychosis, depression, and gener

279 empirical = .11, Q = .15), attention-deficit/hyperactivity disorder (R(2) = .09%, p empirical = .19,

280 disorder (r(g)=0.26), and attention deficit hyperactivity disorder (r(g)=0.23), whereas AUDIT-C scor

281 ssociated with addiction, attention-deficit/ hyperactivity disorder, schizophrenia, and Parkinson's d

282 ectual disability, autism, attention-deficit/hyperactivity disorder, schizophrenia, bipolar disorder,

283 ture of DD overlapped with attention-deficit/hyperactivity disorder, schizophrenia, major depression,

284 autism spectrum disorders, attention deficit/hyperactivity disorder, severe learning disability, cere

285 Attention-deficit/hyperactivity disorder severity was related to age-advan

286 ain Outcomes and Measures: Attention-deficit/hyperactivity disorder symptom trajectories from ages 4

287 itude) relates to specific attention-deficit/hyperactivity disorder symptoms (hyperactivity, but not

288 orted associations between attention-deficit/hyperactivity disorder symptoms and DNA methylation in c

289 ive behavior symptoms, and attention-deficit/hyperactivity disorder symptoms within the borderline/cl

290 , aggressive behavior, and attention-deficit/hyperactivity disorder symptoms, a one-unit increase in

291 udy meta-analysis of adult attention-deficit/hyperactivity disorder symptoms, based on peripheral blo

292 (IQ) and higher levels of attention deficit/hyperactivity disorder symptoms.

293 iated with lower levels of attention deficit/hyperactivity disorder symptoms.

294 ponent in the treatment of attention-deficit hyperactivity disorder, their use continues to prompt in

295 mptoms, anxiety disorders, attention-deficit hyperactivity disorder, Tourette syndrome, post-traumati

296 aturation and diagnosis of attention-deficit/hyperactivity disorder were identified.

297 n when cases with comorbid attention-deficit/hyperactivity disorder were removed from the analysis.

298 on's disease, obesity, and attention-deficit/hyperactivity disorder, were characterized by positive c

299 ptoms of schizophrenia and attention-deficit/hyperactivity disorder, which are characterized by impai

300 ons, with the exception of attention-deficit/hyperactivity disorder, which attenuated the risk of any